Advertisement
Garcia to lead prevention program at MD Anderson

Garcia to lead prevention program at MD Anderson

By Modern Healthcare  |  August 29, 2015

Dr. Joxel Garcia, 53, has been named the inaugural executive director of the University of Texas MD Anderson Cancer Center's prevention and control platform, part of its “Moon Shots Program,” which aims to accelerate and improve cancer survival rates.

Kevin Fitzpatrick named CEO of CancerLinQ

Kevin Fitzpatrick named CEO of CancerLinQ

By Modern Healthcare  |  July 11, 2015

Effective Aug. 3, Kevin Fitzpatrick will become CEO of CancerLinQ, a not-for-profit subsidiary of the American Society of Clinical Oncology.

Celgene pays $1B to enter collaboration with Juno Therapeutics

By Steven Ross Johnson  |  June 30, 2015

Leading biotech firm Celgene Corp. will pay $1 billion to enter into a 10-year collaboration with Juno Therapeutics. The move broadens the company's cancer drug portfolio by gaining access to Juno's budding pipeline of oncology immunotherapies.

Cost, value of treatments for common cancers compared

Cost, value of treatments for common cancers compared

By Sabriya Rice  |  June 22, 2015

A new tool will allow oncologists to compare various drug treatments for four common cancers based on survival, side effects and costs. The framework is part of a broader effort to help physicians and patients choose appropriate therapies amid the skyrocketing costs of cancer drugs.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.